NRBO NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.

$1.38
As of 12/03/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/05/2016
Outstanding shares:  26,593,185
Average volume:  201,260
Market cap:   $39,623,846
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    64132R107
ISIN:        US64132R1077
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.02
PS ratio:   0.00
Return on equity:   -1,089.60%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy